An ear infection occurs when a bacterial or viral infection that affects the inner, middle or outer ear. Ear infections can be painful because of inflammation and fluid buildup in the ear. Acute ear infection can cause mild pain and discomfort in the ear. However chronic cases can cause severe pain, loss of body balance, drainage of fluids from ear, headache and even hearing loss in some cases.
Smoke from a burning cigarette combined with exhaled smoke from a person who smokes increases unhealthy particles in the air, including those of nicotine and other toxins. This increases the microbe growth in such households, which increases the risk of ear infection. This is the major driving factor for the growth of this market. Other factors like unclean and unhealthy environment also increase the risk of ear infection, which leads to growth of ear infection treatment market. However high cost of surgical procedures in severe cases has been restraining the growth of this market.
Key Market Trends
Middle Ear Infection is Expected to Show a High Growth Rate Over the Forecast Period
Middle ear infection also referred to as otitis media, is the most common ear infection, especially in children. According to a study by Kaur R et al. published Pediatric Journal 2017, by 1 year of age, 23% of the children experienced more than one episodes acute otitis media (AOM). By 3 years of age, 60% had more than one episode of AOM, and nearly 24% had more than 3 such episodes. The peak incidence was reported to have occurred at 6 to 12 months of life. It is therefore found that the prevalence is very high for children. Hence the immediate treatment is very necessary. Thus, this treatment for a middle ear infection is expected to occupy a large share of the market.
North America Dominates the Market and Expected to do the Same in the Forecast Period
North America has been accounted for the largest market share of the followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US as there are increasing number of surgeries coupled with the high expenditure on the health care.
However, US has also has a developed and structured healthcare system that encourages research and development among pharmaceutical companies and various research organizations. The healthcare system is also involved in spreading awareness regarding the treatment, which increases its demand. Hence, this region is expected to dominate the market.
Majority of the key player involved in research and manufacturing of Ear Infection Treatment are established in developed countries. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market growth.
The market estimate (ME) sheet in Excel format
3 months of analyst support
Our reports have been used by over 10K customers, including:
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
The anatomic pathology market is projected to reach US$ 33,145.78 million by 2028 from US$ 21,488. 41 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Factors such as increase in the prevalence of cancer and other diseases, and growing focus on personalized medicines. However, the lack of skilled professionals...
The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Executive Summary The global radiation therapy market was valued at USD 5216.04 million in the year 2019, according to a research report published in June 2020. The growth of the radiation therapy market will primarily be supported by an Increasing public health spending as cancer is the second most deadly disease in the...
The global interventional neuroradiology market is expected to reach US$ 3,254.55 Mn in 2027 from US$ 1,969.39 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027. Progressive aging population, increasing demand for minimally invasive procedures and rise in the prevalence of the cerebral aneurysm play vital role...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.